In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

European Journal of Heart Failure

Advancing knowledge in the field of heart failure management

 

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Submit your paper

Fast Facts

  • Editor-in-chief: Michael Böhm (DE)
  • Current volume: 26 (year 2024)
  • Issues per subscription: 12
  • Impact Factor 2022:  18.2

Editor-in-chief History

Name Start Date End Date
Professor John Cleland 01/01/1999 31/12/2004
Professor Karl Swedberg 01/01/2005 31/12/2009
Professor Dirk J. Van Veldhuisen 01/01/2010 31/12/2014
Professor Marco Metra 01/01/2015 31/03/2024
Professor Michael Böhm 01/04/2024  
Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.

Most recent articles from EJHF

25 Apr 2024
Interatrial shunting as a treatment for heart failure: Where do we stand?
Author(s): Thomas M. Gorter, Elke S. Hoendermis, Dirk J. van Veldhuisen
24 Apr 2024
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure?
Author(s): Matteo Pagnesi, Marianna Adamo, Marco Metra
25 Apr 2024
Baroreceptors as a target of device‐based neuromodulation in heart failure: Long‐term outcomes
Author(s): Guido Grassi, Raffaella Dell'Oro, Fosca Quarti‐Trevano
24 Apr 2024
Follow the EMPULSE: In‐hospital initiation of empagliflozin for heart failure across the spectrum of left ventricular ejection fraction
Author(s): Tann Lien, Kishan Srikanth, Andrew P. Ambrosy